TrialDiabetologia2020

An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension.

John P Hanrahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.